EPN’s letter to the Senate urging the inclusion of PFAS amendments to the 2023 National Defense Authorization Act was referenced in this article discussing a National Academy of Sciences’ report that provides recommendations to clinicians who may consider PFAS testing for patients at higher risk of exposure to the chemicals.